KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $12.1 million.

  • Bio-Rad Laboratories' Interest Expenses fell 81.97% to $12.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.0 million, marking a year-over-year increase of 20.45%. This contributed to the annual value of $49.0 million for FY2025, which is 20.45% up from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Interest Expenses of $12.1 million as of Q4 2025, which was down 81.97% from $12.3 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Interest Expenses registered a high of $12.6 million during Q2 2025, and its lowest value of $363000.0 during Q2 2021.
  • For the 5-year period, Bio-Rad Laboratories' Interest Expenses averaged around $9.3 million, with its median value being $12.1 million (2024).
  • Its Interest Expenses has fluctuated over the past 5 years, first tumbled by 9367.6% in 2021, then surged by 310576.92% in 2022.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Interest Expenses stood at $364000.0 in 2021, then surged by 3105.77% to $11.7 million in 2022, then rose by 5.6% to $12.3 million in 2023, then dropped by 0.99% to $12.2 million in 2024, then fell by 0.82% to $12.1 million in 2025.
  • Its Interest Expenses was $12.1 million in Q4 2025, compared to $12.3 million in Q3 2025 and $12.6 million in Q2 2025.